After Hours Most Active for Jun 6, 2025 : IOVA, NVDA, INTC, ACHR, AAL, CSX, AAPL, NKE, PCG, BAC, MRK, PFE

The NASDAQ 100 After Hours Indicator is up 14.86 to 21,776.65 with total after-hours volume of 96,255,289 shares traded; Iovance Biotherapeutics (IOVA), NVIDIA (NVDA), and Intel (INTC) are among the most active stocks. NVDA has seen six up revisions for its fiscal quarter ending July 2025 earnings forecast, with a consensus EPS of $0.94, and several of the most active stocks, including IOVA, NVDA, ACHR, CSX, PCG, and BAC, have a mean recommendation in the "buy range" according to Zacks.

Analysis

The NASDAQ 100 After Hours Indicator advanced 14.86 points to 21,776.65, with robust after-hours volume of 96,255,289 shares, signaling moderately positive market sentiment. NVIDIA Corporation (NVDA) was notably active, gaining $0.06 to $141.78, supported by six upward earnings forecast revisions for its July 2025 quarter and a consensus EPS of $0.94, alongside a "buy range" recommendation from Zacks. Iovance Biotherapeutics (IOVA) rose $0.02 to $2.07, and Archer Aviation Inc. (ACHR) surged $0.98 to $11.17; both also hold "buy range" ratings. Intel Corporation (INTC) increased $0.0299 to $20.09, trading at 95.67% of its $21 target price. In contrast, American Airlines Group (AAL) dipped $0.0097 to $11.77, currently at 90.54% of its $13 target. Multiple other active names like CSX Corporation (CSX), PG&E Corp (PCG), Bank of America Corporation (BAC), and Merck & Company, Inc. (MRK) maintain "buy range" recommendations, with CSX and MRK closing flat. Apple Inc. (AAPL) and Pfizer, Inc. (PFE) posted marginal gains, trading at 86.82% and 86.56% of their respective analyst target prices, while Nike, Inc. (NKE) was nearly unchanged, trading at 89.71% of its $70 target.

Key Decisions for Investors

• Investors should consider NVIDIA's (NVDA) strong outlook, evidenced by upward earnings revisions and a "buy range" recommendation, for potential bullish positions.
• Further due diligence is warranted for actively traded stocks with "buy range" ratings such as Iovance Biotherapeutics (IOVA), Archer Aviation (ACHR), CSX Corporation (CSX), PG&E Corp (PCG), Bank of America (BAC), and Merck (MRK).
• The gap between current prices and analyst targets for Intel (INTC), Apple (AAPL), Nike (NKE), and Pfizer (PFE) may present valuation opportunities, subject to fundamental review.
• American Airlines Group's (AAL) after-hours decline, despite trading below its target price, suggests a cautious approach and monitoring for underlying catalysts.